Impact of presurgical breast MRI in a district general hospital

por Newland, A, Dumba, M, Flais, S
Publicado 2011

Extended opening hours of the one-stop shop

por Flais, S, Dumba, M, Newland, A
Publicado 2011

The significance of aminopeptidases and haematopoietic cell differentiation

por Razak, K, Newland, A.C
Publicado 1992

PB.39. CT or not CT: a systematic review of the breast on CT of the chest and abdomen over 1 year - another screening tool?

por Flais, S, Newland, A, Flais, A, Ellis, B
Publicado 2014

Isolated Gastrointestinal Metastasis of Breast Carcinoma: A Case Report

por Titi, M. A., Anabtawi, A., Newland, A. D.
Publicado 2010

PB.20. Audit of 5 years of routine screening mammography of the reconstructed breast

por Ray, A, McNeilly, L, Newland, A, Flais, S
Publicado 2014

Cytotoxic effects of tumour necrosis factor and gamma-interferon on acute myeloid leukaemia blasts.

por Price, G., Brenner, M. K., Prentice, H. G., Hoffbrand, A. V., Newland, A. C.
Publicado 1987

Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy

por Shamash, J, Oliver, R T D, Gallagher, C J, Newland, A C, Lister, T A, Kelsey, S, Gupta, R K, O'Doherty, C A
Publicado 2000

P1636: PATIENT PREFERENCES AND EXPERIENCES REGARDING THROMBOPOIETIN-RECEPTOR AGONISTS FOR IMMUNE THROMBOCYTOPENIA IN THE NETHERLANDS (TRAPEZE NL STUDY).

por Jansen, A. G., McDonald, V., Newland, A., Morgan, M., Visser-Peereboom, S., Wilson, K., Eriksson, D., Geldman, E., Daykin-Pont, O., Zwaginga, J. J.
Publicado 2022

A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual dis...

por Gottlieb, D. J., Brenner, M. K., Heslop, H. E., Bianchi, A. C., Bello-Fernandez, C., Mehta, A. B., Newland, A. C., Galazka, A. R., Scott, E. M., Hoffbrand, A. V.
Publicado 1989

High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/A...

por Harrison, C N, Gregory, W, Hudson, G Vaughan, Devereux, S, Goldstone, A H, Hancock, B, Winfield, D, MacMillan, A K, Hoskin, P, Newland, A C, Milligan, D, Linch, D C
Publicado 1999

A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National...

por Linch, D. C., Vaughan Hudson, B., Hancock, B. W., Hoskin, P. J., Cunningham, D. C., Newland, A. C., Milligan, D. W., Stevenson, P. A., Wood, J. K., MacLennan, K. A., Anderson, L., Gregory, W. M., Vaughan Hudson, G.
Publicado 1996